The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
about
Advanced glycated end-products affect HIF-transcriptional activity in renal cellsMarkers of oxidative stress and aging in Duchene muscular dystrophy patients and the possible ameliorating effect of He:Ne laser.Therapeutic targeting of signaling pathways in muscular dystrophy.Immune and myodegenerative pathomechanisms in inclusion body myositisPosttranslationally modified proteins as mediators of sustained intestinal inflammation.Wasting mechanisms in muscular dystrophy.Molecular pathology of myofibrillar myopathies.Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.Control of DNA integrity in skeletal muscle under physiological and pathological conditions.Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism.Calpeptin attenuated apoptosis and intracellular inflammatory changes in muscle cellsA monoclonal antibody against the receptor for advanced glycation end products attenuates inflammatory and neuropathic pain in the mouse.S100B protein in skeletal muscle regeneration: regulation of myoblast and macrophage functions.Morphological adaptation of muscle collagen and receptor of advanced glycation end product (RAGE) in osteoarthritis patients with 12 weeks of resistance training: influence of anti-inflammatory or glucosamine treatment.Plasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress.
P2860
Q28591845-9B554D1C-0FFA-4A09-ABD8-3DC3B308F375Q33301531-BC057612-D15B-4A29-AAB7-367268AA71E0Q33707964-46025084-45CF-4A0D-AEAE-FD3B95FF6998Q33753870-BE6151EA-2130-4B9E-8B2E-AB9D03125DF3Q35607249-35C6328C-535D-46ED-AFB5-82123EAFE29EQ37138490-B251D776-279B-4FAB-B2FD-89E03ED1CDDDQ37258743-C2F5EA3C-CACF-4F11-9089-E5320B930F97Q37293352-604C3D2C-2A67-4D26-AE58-10588CAA2869Q37926529-766AE362-6314-4F3C-917F-61983C1F9057Q38819181-1387E470-13C4-47E0-A210-E2D8470F171DQ39417537-9BABC874-ADB2-4395-83D4-57B6A62B3E94Q39598604-2089E625-B16D-4A3C-883D-282B4EA6DD08Q40516938-E23366F9-8187-42BD-ADD7-044A4B1EAD5DQ42917237-336721CE-0524-42DD-BAA8-31737850476AQ45817707-B17C8A16-C9F7-476A-B74E-A3C2BF9D9071Q49117467-750A1D31-BA89-4043-8F7C-4FF892C1C678
P2860
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@ast
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@en
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@nl
type
label
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@ast
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@en
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@nl
prefLabel
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@ast
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@en
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@nl
P2093
P2860
P1476
The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy
@en
P2093
A Bierhaus
A Kirchner
B Neundörfer
E D Schleicher
K M Haslbeck
P P Nawroth
P2860
P2888
P304
P356
10.1007/S00401-005-1043-3
P407
P577
2005-09-01T00:00:00Z
P6179
1033961207